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ABSTRACT 
Background: Previous findings have shown a high degree of comorbid psychopathology 
in chronic low back pain (CLBP), but less is known about the broad range of comorbid 
psychiatric disorders. The prevalence is reported to be between 40%-100% depending on 
methods being used, sample or setting.  
Aims: To assess the prevalence of psychiatric comorbidity in a population of CLBP 
patients, using a psychiatric diagnostic interview. 
Methods: 565 patients sick listed between 2 and 10 months for unspecific LBP were 
included in the study. All were recruited as part of an ongoing trial in secondary care, and 
were assessed with the Mini-International Neuropsychiatric Interview (MINI), which is a 
short structured diagnostic interview for DSM-IV and ICD-10 psychiatric disorders.  
Results: The prevalence of current psychiatric disorders was 31%. The diagnoses 
included 19 Axis I disorders, with the most common being somatoform disorders (18%) 
and anxiety disorders (12%). Major depressive disorders were reported in 4%. There 
were no gender differences in prevalence of psychiatric disorders. 
Conclusions: In a large population of CLBP patients, 31% fulfilled the criteria for at 
least one current psychiatric disorder when measured with a diagnostic interview. The 
diagnoses included a wide range of psychiatric disorders, with the most common being 
somatoform disorders (18%) and anxiety disorders (12%). The results imply that 
screening CLBP patients for psychiatric comorbidity in secondary care is important since 
psychopathology may have serious consequences for prognosis, outcome and health care 
utilization.    
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INTRODUCTION 
Low back pain (LBP) is a common condition that affects large parts of the population, 
with up to 40% of the general population reporting LBP during last month (Ihlebaek et 
al., 2002). Although experienced by the majority, the complaints endure and disable in a 
minority. Chronic LBP (CLBP) is a condition where biological, psychological and social 
factors interact and mutually influence each other, both as causal factors and in 
maintaining the complaints (Dersh et al., 2001; Waddell, 2004a). In CLBP there is a high 
degree of comorbidity with reports of additional somatic and psychological symptoms 
and complaints (Carnes et al., 2007; Hagen et al., 2006; Von Korff et al., 2005). 
Prevalence of comorbid psychiatric disorders is often assessed and considered. In most 
cases questionnaires, and not diagnostic interviews, are conducted (e.g. Currie and Wang, 
2004; Manchikanti et al., 2002; Mok and Lee, 2008).   
 
Studies where diagnostic interviews have been used to assess psychiatric comorbidity in 
CLBP, show consistently high prevalence varying from 41% to 99% (Atkinson et al., 
1991; Dersh et al., 2006; Kinney et al., 1993; Polatin et al., 1993; Reich et al., 1983). The 
most common disorders are somatoform disorders, affective disorders and substance 
abuse disorders, with major depression as the most common single diagnosis (Kinney et 
al., 1993; Polatin et al., 1993). Psychiatric disorders are also significantly more prevalent 
in those reporting CLBP compared to those without CLBP in the general population, as 
seen across 17 countries in the world mental health surveys (Demyttenaere et al., 2007).  
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The fewer structural and neurological deficits found by somatic examinations in CLBP 
patients, the more psychiatric symptoms are present (Mayr et al., 2003). The same 
findings were reported more than 30 years ago in the well known study by Magni and 
Merskey (1987), when patients with pain caused by organic lesions such as disc 
herniation or radicular deficits showed lower prevalence of psychological problems than 
patients with pain where no organic causes were identified (Magni and Merskey, 1987). 
Number of pain complaints has been found to increase the likelihood of psychopathology 
(Katon and Sullivan, 1990), and more widespread pain has been associated with disability 
(Kamaleri et al., 2008). The association between pain and psychopathology are further 
strengthened as severity of either condition increases (Carroll et al., 2000). Concurrent 
psychopathology in CLBP imply poor prognosis (Linton, 2000), poor outcome (Dersh et 
al., 2007) and high health care utilization (Engel et al., 1996), and clinical guidelines 
emphasize the importance of screening for psychopathology in these patients (Airaksinen 
et al., 2006).   
 
A wide range of different questionnaires have been used to assess psychopathology in 
CLBP patients by self-report, but structured clinical interviews like SCID (First et al., 
1997) or MINI (Sheehan et al., 1998) are the gold standard for diagnosing 
psychopathology according to DSM-IV criteria, which is the main diagnostic system 
classifying psychiatric illness. The aim of the study was therefore to assess the prevalence 
of psychiatric comorbidity in a population of CLBP patients through a psychiatric 
diagnostic interview based on DSM-IV and ICD-10 criteria.   
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MATERIALS AND METHODS 
Participants 
574 patients, mean age 45 years and 50.5% women were included in the study. They 
were sick listed for unspecific LBP (International Classification of Primary Care (WHO, 
2003): L03, L04, L84 & L86) and were between 20 and 60 years. One patient dropped 
out and withdrew consent, one patient was excluded after randomization due to high 
suicide risk, and 7 patients have all baseline data missing, leaving 565 patients. All 
patients were consecutive participants in an ongoing trial with different treatments for 
LBP. Over a period of 2 years, patients registered as sick listed (2-10 months) due to LBP 
received information from the National Insurance Administration about the possibility to 
participate in a multicenter randomized controlled trial with different treatments for LBP 
(clinicaltrials.gov, 2010). Those who responded to the invitation (n=2200) were screened 
by telephone and excluded if they did not fulfil the inclusion criteria or could not be 
reached (n=1563). Eligible patients (n=637) were referred to the clinic for inclusion in 
the trial. At the clinic, patients were excluded if one of the following were discovered 
during the medical examination: Pregnancy, osteoporosis (known osteoporotic fracture), 
cancer (currently being treated for cancer), recent back trauma, serious psychiatric 
disorder (mainly due to ongoing psychosis, high suicide risk, and/or serious depression), 
cardiovascular disease, or not fluent in Norwegian language (n=63) (see figure 1 for more 
detailed flowchart). Mean duration of back pain reported by the participants was 11 years 
(see table 1 for more baseline and clinical characteristics).    
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Questionnaires 
All patients answered a number of standard validated Norwegian versions of 
questionnaires. Data reported in this study include demography, pain, psychological 
distress, and health complaints. Anxiety and depression was measured by The Hospital 
Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983). The HADS has been 
found to be a reliable instrument for detecting states of depression and anxiety, and the 
anxiety and depressive subscales are also valid measures of severity of the emotional 
disorder (Bjelland et al., 2002). The scale avoids overlap with somatic symptoms of 
physical illness. It consists of seven depression items and seven anxiety items. Scores for 
each item range from 0-3 and the higher the score the more severe the disorder. A cut off 
score of 8 on both subscales were used because this have been found to give an optimal 
balance between sensitivity and specificity according to DSM-III, DSM-IV, ICD-8, and 
ICD-9 (Bjelland, et al., 2002). Subjective health complaints were measured by 29 items 
from the Subjective Health Complaint Inventory (Eriksen et al., 1999). Subjective 
somatic and psychological complaints experienced during the last 30 days were assessed, 
with severity scored on a 4-point scale. The prevalence on five subscales was calculated: 
musculoskeletal complaints, “pseudoneurological complaints” (extra heartbeats, hot 
flushes, sleep problems, tiredness, dizziness, anxiety, and sadness/depression), 
gastrointestinal complaints, allergy and flu. A revised version of the Brief Pain Inventory 
(BPI) was used to assess pain (Keller et al., 2004). Three single items from the BPI were 
used here. Pain intensity related to activities and rest were both measured on a scale from 
1 (no pain) to 9 (worst possible pain), while back pain intensity the last 14 days was 
measured on a scale ranging from 1 (no pain) to 10 (worst possible pain).  
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Psychiatric interview 
The Mini-International Neuropsychiatric Interview (MINI) was applied as the structured 
diagnostic interview (Sheehan et al., 1998) for DSM-IV (American Psychiatric 
Association, 1994) and ICD-10 (World Health Organization, 1993) assessing psychiatric 
disorders. It is a short structured diagnostic interview, developed jointly by psychiatrists 
and clinicians in the United States and Europe. It is based on “yes” and “no” answers and 
covers 23 Axis 1 disorders. In the multiaxial system of DSM-IV, Axis I disorders include 
all major mental disorders as well as developmental and learning disorders. The MINI 
interview usually takes 15-20 minutes, and has high reliability and validity (Sheehan et 
al., 1998). We used the Norwegian version of MINI Plus (Leiknes et al., 2005). The 
MINI Plus is a version of the MINI interview that is particularly designed for research. It 
features questions on rule-outs (e.g. depressive reaction due to grief), disorder subtyping 
(e.g. somatoform pain disorder related to psychological factors or somatic condition) and 
chronology (e.g. when was the first time you experienced a panic attack?), and includes 
modules for somatisation disorders (e.g. hypochondriasis and somatoform pain disorder). 
MINI Plus further employs different time frames for various disorders: current, past, or 
lifetime. “Current” refers to past 2 weeks (major depression), past month (panic disorder, 
social phobia, obsessive compulsive disorder, PTSD), past 12 months (alcohol 
dependency/abuse), or ongoing at the time of interview with no further time reference 
(mania, agoraphobia, generalized anxiety disorder, psychotic disorders, somatisation 
disorders, anorexia, bulimia). In this way, MINI differs from most other diagnostic 
interviews that usually ask for symptoms within the past 12 months.    
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Procedure 
Eight medical doctors specialised in physical medicine and rehabilitation performed the 
MINI. They had been trained in administration of the MINI interview through a half-day 
seminar. The seminar was lead by an experienced psychiatrist (second author). 
Additionally, interviewers were supervised by a psychologist (first author) 
knowledgeable in MINI administration, who reviewed completed MINI’s and clarified 
any clinical questions regarding the diagnoses. Every interview was audiotaped, and 90 
audiotapes were randomly selected for evaluation by a psychologist (first author) and a 
psychology graduate student. A smaller selection of the audiotapes was double-scored, 
showing good inter-rater reliability. The evaluations showed satisfactory quality in the 
majority of the interviews. If the evaluation revealed that protocol was not followed, 
feedback was given and interviewers were supervised accordingly. However, no 
interviews were considered too poor not to be included in the study. If any of the 
responses the interviewers reported on the MINI-interview appeared unclear or 
ambiguous, the audiotapes were used for clarification.  
 
Statistical procedure 
SPSS version 15 was applied for all analyses. Descriptive statistics (e.g. frequency tables) 
were used when investigating baseline characteristics and prevalence of psychiatric 
disorders, and confidence intervals were calculated for the prevalence of all psychiatric 
disorders. Chi-square statistics were used to investigate potential gender differences. 
MINI diagnoses that were not filled out by the doctors were coded missing. However, 
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when the main category of a disorder was scored 0, the subcategory of this disorder was 
scored 0 as well. For example, if major depressive disorder was scored 0 (meaning no 
diagnosis) and major depressive disorder with melancholia was missing, the latter was 
scored 0 as well. 
 
Ethical considerations 
The study was approved by The Regional Ethical Committee and the Norwegian Social 
Science Data Services National Register of Data. All principles in the Helsinki 
declaration were followed. Informed consent was signed by each participant with 
emphasis on the right to withdraw from the study at any time without any explanation.  
 
 
RESULTS 
99% of the CLBP patients had other health complaints in addition to LBP, with a mean of 
10 subjective health complaints. Mean back pain intensity was 6.4 on a scale from 1 to 
10. According to HADS, 18% were possible cases of depression (score >8) and 21% 
possible cases of anxiety (table 1).  
 
Insert table 1 about here 
 
212 (38%) of the CLBP patients had at least one DSM-IV psychiatric diagnosis (current 
or lifetime), while 169 (31%) presented with a current diagnosis. Based on the total 
number of diagnoses, 117 (21%) had one diagnosis, 35 (6%) had two diagnoses, 32 (6%) 
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had three diagnoses, and 28 (5%) had more than 3 diagnoses. There were no differences 
in total prevalence of psychiatric disorders between women and men (χ=2.370; p=0.134), 
but a comparison of diagnostic categories showed that men had significantly higher 
prevalence of substance abuse than women (χ=7.755; p=0.006).  
 
When the single diagnoses were grouped into diagnostic categories, somatoform 
disorders (18%) and current anxiety disorders (12%) were the most prevalent diagnostic 
categories, while current depressive disorders were seen in only 4% (table 2).  
 
Somatoform pain disorder related to psychological factors was the single most prevalent 
disorder (n=53, 10%), followed by past depressive episode (n=46, 8%), somatoform pain 
disorder related to psychological factors and a general somatic condition (n=33, 6%), 
social anxiety disorder (n=30, 5%) and agoraphobia (n=26, 5%) (table 3).  
 
 
DISCUSSION AND CONCLUSIONS 
In a population of 565 chronic low back pain (CLBP) patients, 38% had at least one 
current or lifetime psychiatric disorder, while 31% had at least one current disorder. The 
most prevalent diagnoses were somatoform disorders and anxiety disorders, while major 
depressive disorders were seen in only 4%. There were no gender differences in 
prevalence of psychiatric disorders.  
 
A comparison with the general population is difficult since most studies report 12 months 
prevalence as opposed to our point prevalence (M.I.N.I. usually asks for symptoms the 
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last 14 days or month). A total of 32.8% of the general population in Norway had a 
current psychiatric disorder, which is almost identical to our findings of 31.4%. Our 
findings showed a lower prevalence of current depression, panic disorder, social phobia 
and alcohol dependency, but higher prevalence of other anxiety disorders (GAD, OCD 
and agoraphobia), drug dependency and somatoform disorders (Kringlen et al., 2001). 
Similar rates were found in a review of epidemiological studies from 16 European 
countries, where a 12 months prevalence of 27% were reported (Wittchen and Jacobi, 
2005). However, assessments of 12 months prevalences generally give higher prevalence 
numbers. In an epidemiological study where 1 month prevalence was measured, the 
prevalence rate of psychiatric disorders was only 15% (e.g. Regier et al., 1988). 
Furthermore, epidemiological studies from several other countries have reported lower 
levels of psychiatric disorders in the general population. In Netherland the prevalence of 
psychiatric disorders within the preceding year was 23% (Bijl et al., 1998), while results 
from six European countries found a 12-months prevalence of 6% anxiety disorders, 4% 
mood disorders, and 1% alcohol disorders (Alonso et al., 2004). Our findings therefore 
imply that CLBP patients present with more psychiatric disorders than the general 
population.  
 
Our prevalence rates of psychiatric disorders in CLBP are lower than previous findings, 
especially for depression (Dersh et al., 2006; Kinney et al., 1993; Polatin et al., 1993; 
Reich et al., 1983). This could be a result of selection bias, i.e. fewer patients with 
psychiatric disorders choosing to participate in the study. It could also be related to an 
underreporting of psychological symptoms resulting in a negative response bias. The 
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possible underreporting may be related to a biomechanical understanding among the 
patients, social stigma related to mental disorders, or the administrators who were 
medical doctors not specialised in psychiatry. Previous studies have found good 
agreement between MINI diagnoses generated by general practitioners and expert 
psychiatrists (Sheehan et al., 1998), but we cannot rule out the possible influence of a 
negative response bias. Other reasons for the lower prevalence in our results could be 
related to a lower educational level of participants in some previous studies (Dersh et al., 
2006; Kinney et al., 1993; Reich et al., 1983) and more female participants in others 
(Reich et al., 1983), both known risk factors for psychiatric disorders. Our results were 
for instance more in line with a study where all participants were men (Atkinson et al., 
1991). A gender difference was on the contrary found for only one disorder (substance 
abuse) in our study and thus weakens gender as an explaining variable. The health care 
system and the compensational systems in North-America and Norway differ widely and 
therefore complicate a direct comparison of the studies. Different settings in which the 
psychiatric interviews were performed might also contribute to the different results, as 
previously proposed by Merskey et al (1987). Our study was conducted in secondary 
care, primarily in spine clinics. This is quite different to some of the comparative studies; 
one in a tertiary setting where the patients had experienced unsuccessful treatments in 
both primary and secondary care (Dersh et al., 2006), and another in a chronic pain clinic 
where the patients had undergone multiple unsuccessful treatment approaches (Reich et 
al., 1983). Considering that previous findings have demonstrated that psychopathology is 
a strong predictor of poor treatment outcome (Dersh et al., 2007; Hasenbring, 1998; 
McCracken and Turk, 2002), patients with a history of multiple unsuccessful treatments 
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would be expected to present with more psychiatric comorbidity. Repeated experiences 
of failed treatments could further result in a feeling of helplessness and hopelessness for 
the individual, where all attempts of help leads to no change or maybe even worse 
outcomes (Ursin and Eriksen, 2004). These experiences will most likely trap the 
individual in a vicious circle of pain, disability, low coping and an increasing level of 
comorbidity, including psychiatric disorders.  
 
Compared with the results from the world mental health surveys (Demyttenaere et al., 
2007), our results appear less deviant. In fact, our prevalences of psychiatric disorders are 
all within the range of those found in people who reported chronic back or neck pain 
across the different countries (Demyttenaere et al., 2007). Our results are in the lower 
range of estimates for depression and upper range for anxiety disorders and alcohol abuse 
disorder. Prevalence estimates from the US were consistently higher than the rest of the 
world in the world mental surveys (Demyttenaere et al., 2007). This supports the 
previously presented hypothesis of cultural differences or differences in health care 
systems.  
 
Chronic back pain patients are by some regarded to be somatising patients who express 
psychological and social distress through persistent subjective health complaints (Ford, 
1983). This is reflected in the extremely high prevalence of somatoform pain disorders 
often found in chronic back pain populations, with 99% diagnosed by some (Kinney et 
al., 1993). It may be argued that a high prevalence of somatoform pain disorder is 
universally descriptive of the population and therefore not necessary to report (Dersh et 
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al., 2006). However, in our results only 16% of the CLBP patients were diagnosed with a 
somatoform pain disorder. Whether this was due to more strict diagnostic criteria, 
underreporting, or other characteristics of the population is hard to say, but it is an 
interesting finding that challenges the notion that the majority of CLBP patients suffer 
from somatoform pain disorder. The first question of the somatoform pain disorder 
module is: “is pain currently your main problem?”, and the fact that more than one third 
of the participants, all sick listed for pain in their lower back, answered no to this 
question, is interesting. The most intuitive explanation of this might simply be that other 
complaints or problems besides pain are the main concern of a large proportion of the 
group. The CLBP patients present with a high number of subjective health complaints 
and psychiatric disorders which could be one explanation. Alternatively other problems 
like marital, financial, or work-related problems could be their greatest concern, and 
could all be part of the vicious circle of chronicity (Hagen, 2006). One way to follow up 
on this could be to ask the participants to rate their main concerns on a list where all 
kinds of problems were included.   
 
The magnitude of undetected psychiatric illness in primary care is widely recognized 
(Christensen et al., 2003; Goldberg and Bridges, 1987; Paykel and Freeling, 1992) and 
involves consequences such as undertreatment (Overland et al., 2007) and increased costs 
due to disability pensions (Mykletun et al., 2006). Screening for psychiatric disorders in 
secondary care therefore appears vital since psychiatric comorbidity in CLBP may have 
serious consequences for prognosis (Linton, 2000), outcome (Dersh et al., 2007) and 
health care utilization (Engel et al., 1996).  
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In conclusion, 31% of a large population of CLBP patients fulfilled the criteria for at least 
one current psychiatric disorder when measured with a diagnostic interview. The 
diagnoses included a wide range of psychiatric disorders, with the most common being 
somatoform disorders (18%) and anxiety disorders (12%). The results imply that 
screening CLBP patients for psychiatric comorbidity in secondary care is important since 
psychopathology may have serious consequences for prognosis, outcome and health care 
utilization.   
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TABLES 
Table 1. Baseline and clinical characteristics (n=565) 
Continuous variables  Mean  SD Median 
Age 45 years 9.8 45 
Duration of back pain 11 years 10.6 7.5 
Back pain intensity (1-10) 6.5 1.9 7.0 
Pain during activity (1-10) 5.9 2.2 6.0 
Pain while resting (1-10) 4.0 2.2 4.0 
Subjective health complaints, number of 
complaints 
10.0 4.9 10.0 
Categorical variables  n %  
Gender  
      Men 
      Women 
 
273 
279 
 
49.5 
50.5 
 
Civil status 
     Married/cohabitant  
     Single/widow/divorced 
 
396 
156 
 
71.7 
28.2 
 
Education 
     Primary school 1-12 years 
     University/college 
     Other 
 
344 
164 
42 
 
62.5 
29.8 
7.6 
 
HAD 
     Depression (score >8) 
     Anxiety (score >8)     
 
95 
115 
 
17.5 
21.0 
 
Is pain currently your main problem? 
    Yes 
     No 
 
375 
177 
 
67.6 
31.9 
 
Subjective health complaints      
     Musculoskeletal complaints 
     Pseudoneurological complaints 
     Gastrointestinal complaints 
     Allergy 
     Flu 
 
528 
477 
360 
243 
228 
 
99.2 
89.7 
67.5 
45.6 
42.9 
 
 
 
Table 2. Summary of the main diagnostic categories from the MINI diagnostic  
interview (n=565)  
 
Main diagnostic categories 
 
n 
 
% 
 
(95% CI) 
Any somatoform disorders, current 97 17.9 (14.6-21.1) 
Any depressive disorders, current 20 3.6 (2.1-5.2) 
Any depressive disorders, past 54 9.8 (7.3-12.2) 
Any anxiety disorders, current 69 12.4 (9.7-15.2) 
Any anxiety disorders, past 42 7.6 (5.4-9.9) 
Any substance disorder (lifetime and current) 21 3.8 (2.2-5.4) 
  Prevalence of psychiatric disorders 
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Table 3. Prevalence of single diagnoses from the MINI diagnostic interview (the total is 
more than 38% because of the presence of comorbidities) (n=565) 
 
Axis 1 Disorder 
 
n 
 
% 
 
 (95% CI) 
MINI positive (any DSM-IV Axis I diagnosis) 212 38.2 (34.2-42.2) 
Any current disorder 169 31.4 (27.5-35.3) 
Somatoform disorders    
    Hypochondrias 18 3.2     (1.8-4.7) 
    Somatoform pain disorder related to psychological factors 53 9.6      (7.2-12.1) 
    Somatoform pain disorder related to psychological factors    
    and a general somatic condition 
33 6.0    (4.0-8.0) 
    Somatisation disorder, lifetime 6 1.1     (0.2-2.0) 
    Somatisation disorder, present 6 1.1     (0.2-2.0) 
Anxiety disorders    
    Generalized anxiety disorder (GAD), current 23 4.1     (2.5-5.8) 
    Panic disorder, lifetime 25 4.5     (2.8-6.2) 
    Panic disorder, current 7 1.3     (0.3-2.2) 
    Agoraphobia, lifetime 26 4.7     (3.0-6.5) 
    Agoraphobia, current 21 3.8     (2.2-5.4) 
    Social anxiety disorder, current 30 5.4     (3.5-7.3) 
    Obsessive-compulsive disorder (OCD), current  6 1.1     (0.2-1.9) 
    Post traumatic stress disorder (PTSD), current 3 0.6     (-0.1-1.2) 
Substance use disorders    
    Alcohol abuse/dependence, current 12 2.2     (1.0-3.4) 
    Alcohol abuse/dependence, lifetime 12 2.2     (1.0-3.4) 
    Drug abuse/dependence, current or lifetime 6 1.1    (0.2-1.9) 
Eating disorders    
    Anorexia nervosa 0 0  
    Bulimia nervosa 3 0.5    (-0.1-1.2) 
Affective disorders    
    Major depressive episode, current 17 3.1     (1.6-4.5) 
    Major depressive episode, past   46 8.3     (6.0-10.6) 
    Major depressive episode with melancholia, current  7 1.3     (0.3-2.2) 
    Major depressive episode with melancholia, past  9 1.6     (0.6-2.7) 
    Dysthymia, current 3 0.5     (-0.1-1.2) 
    Dysthymia, past  2 0.4     (-0.1-0.9) 
    Manic episode, current 0 0  
    Manic episode, past 6 1.1     (0.2-1.9) 
Suicide – minor to moderate risk 35 6.5     (4.4-8.6) 
Psychotic disorder, current or lifetime 2 0.4     (-0.1-0.9) 
 
 
 
